miércoles, 4 de diciembre de 2019

FDA and MHRA Good Clinical Practice Symposium: Data Integrity in Global Clinical Trials - Tackling Challenging Topics in 2020 - February 13 and 14, 2020 - London, England




The U.S. Food and Drug Administration (FDA) and United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) are pleased to announce the Good Clinical Practice (GCP) Symposium will be taking place on February 13 and 14, 2020 in London, England.

This event will provide regulatory perspectives on the importance of sponsor oversight of clinical sites and laboratories, eSource including electronic health records, protocol deviations including the impact on clinical trials and the challenges in ensuring data quality in novel clinical trial designs. Participants of the workshop will have opportunities to work on relevant case studies on these topics.

Registration:
  • Participants can register with MHRA to attend the event. Day one will be available through a livestream for those unable to attend in person.   
Date and time:
  • Thursday, February 13, 2020 8:30 AM -5:30 PM GMT (livestream available on day one only)
  • Friday, February 14, 2020 8:00 AM – 2:00 PM GMT
Location:
  • Novotel London West Hotel- 1 Shortlands, Hammersmith, London. W6 8DR, UK
Engage in the conversation: #MHRAGCP20

No hay comentarios: